Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes.

Todeschini, G; Veneri, D; Carlini, S; Pizzolo, G; Ambrosetti, A; Bonesi, R; Cassibba, V; Vinante, F; Meneghini, V; Perona, G

Todeschini, G; Veneri, D; Carlini, S; Pizzolo, G; Ambrosetti, A; Bonesi, R; Cassibba, V; Vinante, F; Meneghini, V; Perona, G.

Affiliation

Todeschini G; Cattedra di Ematologia, Università di Verona, Italy.

Hematol Oncol ; 9(3): 137-46, 1991.

Article in En | MEDLINE | ID: mdl-1937406

Subject(s)

Agranulocytosis/drug therapy; Amikacin/therapeutic use; Ceftazidime/therapeutic use; Fever/drug therapy; Leukemia/drug therapy; Agranulocytosis/complications; Bacteremia/drug therapy; Bacterial Infections/drug therapy; Fever/complications; Humans; Pneumonia/complications

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Amikacin / Leukemia / Ceftazidime / Agranulocytosis / Fever Limits: Humans Language: En Journal: Hematol Oncol Year: 1991 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links